Angus Derek C, Pereira Carlos Alberto Pires, Silva Eliezer
Department of Critical Care Medicine, University of Pittsburgh, Pittsburgh, PA, USA.
Endocr Metab Immune Disord Drug Targets. 2006 Jun;6(2):207-12. doi: 10.2174/187153006777442332.
Severe sepsis is an ongoing challenge for clinicians and health-care administrators mainly because is associated with a high incidence, mortality rate and costs. In recent years, several epidemiological studies about the incidence of sepsis have come out in different and prestigious journals. However, it is not advisable to draw direct conclusions from those studies considering methodological flaws or even different approaches. Hence, we have to be familiar with those obstacles and know how to overcome them. This review paper highlights the methods which have been used in these studies and depicts the results of occurrence rate or incidence of sepsis in countries and in intensive care units.
严重脓毒症对临床医生和医疗保健管理人员来说一直是一项挑战，主要是因为它具有高发病率、死亡率和成本。近年来，不同的权威期刊发表了几项关于脓毒症发病率的流行病学研究。然而，考虑到方法上的缺陷甚至不同的研究方法，直接从这些研究中得出结论是不可取的。因此，我们必须熟悉这些障碍并知道如何克服它们。这篇综述文章重点介绍了这些研究中使用的方法，并描述了各国及重症监护病房中脓毒症的发生率或发病率结果。
